Cours TrovaGene Inc Nasdaq
Actions
US8972384080
Recherche biotechnologique et médicale
CA 2024 * | 442 k 400 k | CA 2025 * | - | Capitalisation | 157 M 143 M |
---|---|---|---|---|---|
Résultat net 2024 * | -45 M -40,75 M | Résultat net 2025 * | -57 M -51,61 M | VE / CA 2024 * | 356 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | - |
PER 2024 * |
-3,59
x | PER 2025 * |
-3,32
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 92,29% |
Dernier transcript sur TrovaGene Inc
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mark Erlander
CEO | Chief Executive Officer | 64 | 04/03/13 |
James Levine
DFI | Director of Finance/CFO | 53 | 12/07/21 |
Tod Smeal
CTO | Chief Tech/Sci/R&D Officer | 59 | 11/01/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
James Armitage
BRD | Director/Board Member | 77 | 22/04/20 |
Gary Pace
BRD | Director/Board Member | 76 | 22/04/20 |
Mark Erlander
CEO | Chief Executive Officer | 64 | 04/03/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,69% | 47,9 Md | |
+46,90% | 41,42 Md | |
-3,46% | 40,7 Md | |
-6,20% | 28,92 Md | |
+9,17% | 25,55 Md | |
-20,42% | 19,27 Md | |
+0,17% | 12,15 Md | |
+28,07% | 12,14 Md | |
-1,24% | 11,99 Md |